Elekta, SE0000163628

Marshall Wace becomes public short seller in Elekta stock

Published on 10/18/2026 at 12:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Marshall Wace became a public short seller in Elekta on October 16, 2026. Elekta stock has a November 25 report date and SEK 3.54 billion in Q1 revenue.

Short interest and operating signals

  • Marshall Wace became a public short seller in Elekta on October 16, 2026.
  • Elekta generated SEK 3.54 billion in first-quarter revenue for fiscal 2027.
  • Elekta scheduled its second-quarter report for November 25, 2026.
Architektonisches 3D-Render eines modernen Forschungsgebäudes repräsentiert die Innovationskraft von Elekta AB SE0000163628 in der Medizintechnik, Illustration mit AI erstellt.

Elekta (ISIN SE0000163628) had one newly listed public short seller, Marshall Wace, on October 16, 2026, according to Affarsvarlden. The market event arrives while the company prepares to report second-quarter results on November 25, 2026.

Affarsvarlden lists first-quarter fiscal 2027 revenue at SEK 3.54 billion and operating profit at SEK 395 million. First-quarter net income was SEK 261 million, while the operating margin reached 11.20 percent.

Three dated Elekta developments

On September 27, 2026, Elekta announced an expanded adaptive radiotherapy portfolio covering CT, MR, radiosurgery and brachytherapy through Elekta. On September 28, 2026, a company study covering 123 pancreatic cancer patients reported overall survival of 37.40 percent at two years. On October 16, 2026, Marshall Wace was listed as one new public short seller in Elekta, according to Affarsvarlden.

What does the next report test?

The November 25 report will put the first-quarter figures into a broader trend. Revenue of SEK 3.54 billion was lower than the prior quarter's SEK 4.76 billion, while net income improved from a loss of SEK 866 million in the fourth quarter to SEK 261 million in the first quarter, based on the financial table published by Affarsvarlden. That comparison makes the next report important for judging whether the improved profit profile can continue.

Dates for the next reports

Elekta lists November 25, 2026 for the second-quarter report. The following quarterly report is scheduled for February 25, 2027, according to the company calendar.

Short interest meets operating data

The latest operating figures combine an 11.20 percent margin with SEK 3.54 billion in first-quarter revenue, while the October 16 short-selling disclosure adds a separate market signal.

Elekta stock facts

  • Company: Elekta AB (publ)
  • ISIN: SE0000163628
  • Ticker: EKTA-B.ST
  • Primary exchange: Nasdaq Stockholm
  • Sector / Industry: Healthcare / Medical Devices

Market context: Market report OMXS30.

More news and analyses on Elekta stock

Disclaimer...
en | SE0000163628 | ELEKTA | boerse | 70353007 | bgmi